These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 14996964

  • 1. Cavitatory pulmonary tuberculosis in a 52-day-old infant.
    Choudhary J, Mubarik M, Parvez A, Naikoo MA.
    J R Soc Med; 2004 Mar; 97(3):131. PubMed ID: 14996964
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pyrazinamide and rifampin vs isoniazid for the treatment of latent tuberculosis: improved completion rates but more hepatotoxicity.
    McNeill L, Allen M, Estrada C, Cook P.
    Chest; 2003 Jan; 123(1):102-6. PubMed ID: 12527609
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of tuberculosis with rifamycin-containing regimens in immune-deficient mice.
    Zhang M, Li SY, Rosenthal IM, Almeida DV, Ahmad Z, Converse PJ, Peloquin CA, Nuermberger EL, Grosset JH.
    Am J Respir Crit Care Med; 2011 May 01; 183(9):1254-61. PubMed ID: 21330452
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA, Ursov IG.
    Probl Tuberk Bolezn Legk; 2004 May 01; (3):21-6. PubMed ID: 15338895
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Chemotherapeutic potential of orally administered poly(lactide-co-glycolide) microparticles containing isoniazid, rifampin, and pyrazinamide against experimental tuberculosis.
    Ul-Ain Q, Sharma S, Khuller GK.
    Antimicrob Agents Chemother; 2003 Sep 01; 47(9):3005-7. PubMed ID: 12937014
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anti-tuberculosis 4FDC tablets--mystery to chemistry.
    Dekker TG, Lötter AP.
    Int J Tuberc Lung Dis; 2003 Mar 01; 7(3):205-6. PubMed ID: 12661831
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Isolation obligation and therapy in tuberculosis].
    Sybrecht GW.
    Dtsch Med Wochenschr; 1997 Oct 10; 122(41):1265. PubMed ID: 9378057
    [No Abstract] [Full Text] [Related]

  • 18. Medical advances with international impact.
    James JS.
    AIDS Treat News; 1998 Mar 06; (No 290):5-7. PubMed ID: 11365120
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.